New insights into the pathological role of TNF-α in early cardiac dysfunction and subsequent heart failure after infarction in rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Berthonneche, C ^a,b   Sulpice, T ^b   Boucher, F ^a   Gouraud, L ^b   De Leiris, J ^a   O'Connor, S E ^b   Herbert, J M ^b   Janiak, P ^b  

^a UNIV GRENOBLE ALPES   (France)

^b SANOFI   (France)

Author keywords

Cardiac geometry; Hemodynamics; Myocardial infarction

Indexed keywords

RECOMBINANT TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEOMETRY; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RAT; TISSUE LEVEL;

EID: 3042577374     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01210.2003     Document Type: Article

References (38)

1. Anker SD and Coats AJ. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 86: 123-130, 2002.
2. Bozkurt B, Kribbs SB, Clubb FJ, Michael LH, Didenko V, Hornsby PJ, Seta Y, Spinale FG, and Mann DL. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97: 1382-1391, 1998.
3. Bozkurt B, Torre-Amione G, Warren MS, Whitmore J, Soran OZ, Feldman AM, and Mann DL. Results of targeted anti-tumor necrosis factor therapy with etanercept (Enbrel) in patients with advanced heart failure. Circulation 103: 1044-1047, 2001.
4. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, and Giroir B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation 97: 1375-1381, 1998.
5. Cheng XS, Shimokawa H, Momii H, Oyama J, Fukuyama N, Egashira K, Nakazawa H, and Takeshita A. Role of superoxide anion in the pathogenesis of cytokine-induced myocardial dysfunction in dogs in vivo. Cardiovasc Res 42: 651-659, 1999.
6. Chung MK, Gulick TS, Rotondo RE, Schreiner GF, and Lange LG. Mechanism of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: impairment of signal transduction. Circ Res 67: 753-763, 1990.
7. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, and Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 57: 387-389, 1992.
8. Fletcher PJ, Pfeffer JM, Pfeffer MA, and Braunwald E. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Circ Res 49: 618-629, 1981.
9. Hutchins GM and Bulkey BH. Infarct expansion vs. extension: two different complications of acute myocardial infarction. Am J Cardiol 41: 1127-1132, 1978.
10. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen WH, Shou Z, and Liu P. Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation 99: 1492-1498, 1999.
11. Jacobs M, Saufenberger S, Gergs U, Meuter K, Brandstätter K, Hafner M, Ertl G, and Schorb W. Tumor necrosis factor-α at acute myocardial infarction in rats and effects on cardiac fibroblasts. J Mol Cell Cardiol 31: 1949-1959, 1999.
12. Kapadia S, Torre-Amione G, Yokoyam T, and Mann DL. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-α in vitro. Am J Physiol Heart Circ Physiol 268: H517-H525, 1995.
13. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, and Mann DL. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ Res 81: 187-195, 1997.
14. Klein B and Brailly H. Cytokine-binding proteins: stimulating antagonists. Immunol Today 16: 216-220, 1995.
15. Krown KA, Page MT, N'Guyen C, Zechner D, Gutierrez V, Comstock KL, Quintana PJE, and Sabbadini RE. Tumor necrosis factor-α-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac death. J Clin Invest 98: 2854-2865, 1996.
16. Kubota T, McTiernan CF, Frye CS, Slawson SE, Koretsky AP, Demetris AJ, and Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-α. Circ Res 81: 627-635, 1997.
17. Kurrelmeyer KA, Michael LH, Baumgarten G, Taffet GE, Peschon JJ, Sivasubramanian N, Entman ML, and Mann DL. Endogenous tumor necrosis factor protects the adult cardiac myocytes against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA 97: 5456-5461, 2000.
18. Levine B, Kalman J, Mayer L, Fillit HM, and Packer M. Elevated circulating levels of tumor necrosis factor-α in severe heart chronic failure. N Engl J Med 323: 236-241, 1990.
19. Li YY, Feng YQ, Kadokami T, McTiernan CF, Draviam R, Watkins SC, and Feldman AM. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor-α can be modulated by anti-tumor necrosis factor-α therapy. Proc Natl Acad Sci USA 97: 12746-12751, 2000.
20. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91: 988-998, 2002.
21. McLellan WR and Schneider MD. Death by design: programmed cell death in cardiovascular biology and disease. Circ Res 81: 137-144, 1997.
22. Nachlas MM and Schnitka TK. Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol 42: 379-405, 1963.
23. Nakano M, Knowlton AA, Dibbs Z, and Mann DL. Tumor necrosis factor-α confers resistance to injury induced by hypoxic injury in the adult mammalian cardiac myocytes. Circulation 97: 1392-1400, 1998.
24. Ono K, Matsumori A, Shioi T, Furukawa Y, and Sasayama S. Cytokine gene expression after myocardial infarction in rat heart: possible implication in left ventricular remodeling. Circulation 98: 149-156, 1998.
25. Pfeffer JM, Pfeffer MA, and Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57: 84-95, 1985.
26. Pfeffer MA and Braunwald E. Ventricular remodeling after myocardial infarction: experimental and clinical implications. Circulation 81: 1161-1172, 1985.
27. Pfeffer MA and Pfeffer JM. Ventricular enlargement and reduced survival after myocardial infarction. Circulation 75: IV93-IV97, 1987.
28. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, and Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 44: 503-512, 1979.
29. Rubin SA, Fishbein MC, and Swan HJC. Compensatory hypertrophy in the heart after myocardial infarction in the rat. J Am Coll Cardiol 6: 1435-1441, 1983.
30. Selye H, Bajusz E, Grasso S, and Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rats. Angiology 11: 398-407, 1960.
31. Silvestre JB, Heymes C, Oubénaïssa A, Robert V, Aupetit-Faisant B, Carayon A, Swynghedauw B, and Delcayre C. Activation of cardiac aldosterone production in rat myocardial infarction: effects of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 99: 2694-2701, 1999.
32. Sivasubramanian N, Cocker ML, Kurrelmeyer KM, McLellan WR, DeMayo FJ, Spinale FG, and Mann DL. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104: 826-831, 2001.
33. Sulpice T, Boucher F, and de Leiris J. Limiting lipid peroxidation in the nonischemic zone of infarcted rat hearts by indomethacin improves left ventricular function without affecting myocardial healing and remodeling. Am Heart J 131: 681-688, 1996.
34. Wollert KC and Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res 43: 838-849, 1999.
35. Xianzhong M, Ao L, Meldrum DR, Cain BS, Shames BD, Selzman CH, Banerjee A, and Harken AH. TNF-α and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am J Physiol Regul Integr Comp Physiol 275: R502-R508, 1998.
36. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, and Mann DL. Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 95: 1247-1252, 1997.
37. Yokoyama T, Sekiguchi K, Tanaka T, Tomaru K, Arai M, Suzuki T, and Nagai R. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 276: H1968-H1976, 1999.
38. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, and Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 92: 2303-2312, 1993.